MCRB

MCRB

USD

Seres Therapeutics Inc. Common Stock

$7.940-0.080 (-0.998%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$8.020

High

$8.250

Low

$7.870

Volume

0.09M

Company Fundamentals

Market Cap

69.3M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.09M

Exchange

NMS

Currency

USD

52-Week Range

Low $6.53Current $7.940High $30.6

Related News

GlobeNewswire

Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced the Company will be presenting new exploratory

View more
Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting
Analyst Upgrades

Chardan Capital Downgrades Seres Therapeutics to Neutral, Raises Price Target to $6

Chardan Capital analyst Keay Nakae downgrades Seres Therapeutics from Buy to Neutral and raises the price target from $1.25 to $6.

View more
Chardan Capital Downgrades Seres Therapeutics to Neutral, Raises Price Target to $6